There were significantly higher levels of CD44, CD133, and VDR expression in HGSC than in non-HGSC ovarian cancers (p = 0.015, p = 0.035, and p = 0.001, respectively) (Figure 2A). Here, CD44 is linked to ovarian carcinoma.